9款重磅疗法上市!2025上半年获批肺癌新药全盘点

药时代
Jul 01

来源:药渡撰文:弘毅编辑:维他命2025年上半年,全球肺癌治疗领域迎来历史性突破,9款创新药物相继在中美获批上市。这不仅标志着肺癌精准治疗进入新纪元,更预示着一个超200亿美元市场的格局正在被重塑。对于中国每年新增的82万肺癌患者而言,尤其是占比高达40%-60%的EGFR突变人群,这些新药意味着从"生存希望"到"治愈可能"的跨越。9款新药覆盖四大突变类型生存期翻倍成常态表1. 根据美国FDA官网...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10